Skip to main content
. 2022 Feb 5;12(3):e4314. doi: 10.21769/BioProtoc.4314

Figure 7. Plaque reduction assay for HCoV-NL63.

Figure 7.

A. Titration of HCoV-NL63 in the RD cell line. B. Determination of EC50 value for remdesivir against HCoV-NL63 in plaque assay. C. Determination of EC50 value for GC-376 against HCoV-NL63 in plaque assay. D. EC50 curve fitting for remdesivir obtained in GraphPad Prism 8. E. EC50 curve fitting for GC-376 obtained in GraphPad Prism 8. F. Titration of HCoV-NL63 in the Huh-7 cell line. G. Titration of HCoV-NL63 in the MRC-5 cell line. H. Titration of HCoV-NL63 in the RD cell line. The images are representatives of three independent repeats.